Association Between Wearable Device–Based Measures of Physical Frailty and Major Adverse Events Following Lower Extremity Revascularization | Zendy

Bijan Najafi | Zendy; Narek Veranyan | Zendy; Alejandro ZulbaranRojas | Zendy; Catherine Park | Zendy; Hung Nguyen | Zendy; Quinn Kaleikaumaka Nakahara | Zendy; Hector Elizondo-Adamchik | Zendy; Jayer Chung | Zendy; Joseph L. Mills | Zendy; Miguel Montero-Baker | Zendy; David G. Armstrong | Zendy; Vincent L. Rowe | Zendy

Open Access

Association Between Wearable Device–Based Measures of Physical Frailty and Major Adverse Events Following Lower Extremity Revascularization

Author(s) -

Bijan Najafi,

Narek Veranyan,

Alejandro ZulbaranRojas,

Catherine Park,

Hung Nguyen,

Quinn Kaleikaumaka Nakahara,

Hector Elizondo-Adamchik,

Jayer Chung,

Joseph L. Mills,

Miguel Montero-Baker,

David G. Armstrong,

Vincent L. Rowe

Publication year - 2020

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2020.20161

Subject(s) - medicine , revascularization , gait , cohort , physical therapy , incidence (geometry) , stride , physical medicine and rehabilitation , physics , myocardial infarction , optics

Key Points Question Is a wrist-worn frailty meter (FM) that quantifies physical frailty using a 20-second repetitive elbow flexion-extension test a feasible tool for evaluating the risk of 30-day major adverse events (MAEs) after lower-limb revascularization? Findings In this 2-center cohort-study of 152 patients, all participants were able to perform the FM test within 1 week before revascularization, whereas most were unable to perform a gait test because of the presence of foot ulcers. The FM distinguished between those with and without 30-day MAEs. Meaning The results of this study suggest that the FM is feasible and may support surgeons in evaluating the risks and benefits of revascularization in older adults.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research